1,1-dichloroethene increases expression ISO RGD:1315665 6480464 vinylidene chloride results in increased expression of C1QC mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1315665 6480464 1, 2-Dimethylhydrazine results in increased expression of C1QC mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of C1QC mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:1315665 6480464 Ethinyl Estradiol results in increased expression of C1QC mRNA CTD PMID:12072388 17beta-estradiol affects expression ISO RGD:1315665 6480464 Estradiol affects the expression of C1QC mRNA CTD PMID:15598610 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QC mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:1315665 6480464 Estradiol results in increased expression of C1QC mRNA CTD PMID:19484750 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QC mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1315664 6480464 Tetrachlorodibenzodioxin results in increased expression of C1QC mRNA CTD PMID:20044593 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1315665 6480464 Tetrachlorodibenzodioxin affects the expression of C1QC mRNA CTD PMID:24680724 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of C1QC mRNA CTD PMID:21215274 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1315665 6480464 Tetrachlorodibenzodioxin results in decreased expression of C1QC mRNA CTD PMID:20044593 2,4,6-tribromophenol decreases expression ISO RGD:1315664 6480464 2 more ... CTD PMID:31675489 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1315665 6480464 Trinitrobenzenesulfonic Acid results in increased expression of C1QC mRNA CTD PMID:17982090 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1315664 6480464 tetrabromobisphenol A results in decreased expression of C1QC protein CTD PMID:31675489 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of C1QC mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of C1QC mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:1315665 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of C1QC mRNA CTD PMID:30951980 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of C1QC mRNA CTD PMID:21346803 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases expression EXP 6480464 Omeprazole results in decreased expression of C1QC mRNA CTD PMID:25626140 7,12-dimethyltetraphene affects expression ISO RGD:1315665 6480464 9 more ... CTD PMID:21785161 acetamide increases expression EXP 6480464 acetamide results in increased expression of C1QC mRNA CTD PMID:31881176 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of C1QC mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:1315664 6480464 Aflatoxin B1 results in decreased methylation of C1QC exon CTD PMID:30157460 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of C1QC mRNA CTD PMID:33354967 amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of C1QC mRNA CTD PMID:22341215 antirheumatic drug decreases expression ISO RGD:1315664 6480464 Antirheumatic Agents results in decreased expression of C1QC mRNA CTD PMID:24449571 aristolochic acid multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of C1QC mRNA CTD PMID:23912714 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA CTD PMID:33854195 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of C1QC mRNA CTD PMID:21839799 benzo[a]pyrene decreases methylation ISO RGD:1315664 6480464 Benzo(a)pyrene results in decreased methylation of C1QC 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1315665 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of C1QC mRNA] CTD PMID:22228805 bisphenol A increases expression ISO RGD:1315665 6480464 bisphenol A results in increased expression of C1QC mRNA CTD PMID:23798566 bisphenol A increases methylation ISO RGD:1315665 6480464 bisphenol A results in increased methylation of C1QC promoter CTD PMID:27312807 bisphenol A decreases expression ISO RGD:1315665 6480464 bisphenol A results in decreased expression of C1QC mRNA CTD PMID:25594700 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of C1QC mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1315665 6480464 bisphenol F results in increased expression of C1QC mRNA CTD PMID:30951980 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of C1QC mRNA CTD PMID:19167457 cadmium atom affects binding ISO RGD:1315664 6480464 C1QC protein binds to Cadmium CTD PMID:23896426 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of C1QC mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:1315664 6480464 Calcitriol results in decreased expression of C1QC mRNA CTD PMID:26485663 cannabidiol multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [Ketamine results in decreased expression of C1QC mRNA] CTD PMID:31823199 captan decreases expression ISO RGD:1315665 6480464 Captan results in decreased expression of C1QC mRNA CTD PMID:31558096 carbon nanotube increases expression ISO RGD:1315665 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone increases expression ISO RGD:1315665 6480464 Chlordecone results in increased expression of C1QC mRNA CTD PMID:33711761 chlormequat chloride increases expression EXP 6480464 Chlormequat results in increased expression of C1QC protein CTD PMID:34958886 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA CTD PMID:33854195 chlorpyrifos increases methylation EXP 6480464 Chlorpyrifos results in increased methylation of C1QC gene CTD PMID:32905263 copper atom affects binding ISO RGD:1315664 6480464 C1QC protein binds to Copper CTD PMID:23896426 copper(0) affects binding ISO RGD:1315664 6480464 C1QC protein binds to Copper CTD PMID:23896426 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of C1QC mRNA CTD PMID:21865292 diclofenac increases expression ISO RGD:1315665 6480464 Diclofenac results in increased expression of C1QC mRNA CTD PMID:26934552 disodium selenite decreases expression ISO RGD:1315665 6480464 Sodium Selenite results in decreased expression of C1QC mRNA CTD PMID:23274088 diuron decreases expression EXP 6480464 Diuron results in decreased expression of C1QC mRNA CTD PMID:25152437 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of C1QC mRNA CTD PMID:32289291 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of C1QC mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:1315665 6480464 Ethanol results in increased expression of C1QC mRNA CTD PMID:30319688 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of C1QC mRNA CTD PMID:24136188 folpet decreases expression ISO RGD:1315665 6480464 folpet results in decreased expression of C1QC mRNA CTD PMID:31558096 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of C1QC mRNA CTD PMID:21081137 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA CTD PMID:33854195 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA CTD PMID:33854195 indoles decreases expression EXP 6480464 Indoles results in decreased expression of C1QC mRNA CTD PMID:20521778 indoles increases expression EXP 6480464 Indoles results in increased expression of C1QC mRNA CTD PMID:20521778 irinotecan multiple interactions ISO RGD:1315665 6480464 [PHY 906 co-treated with Irinotecan] affects the expression of C1QC mRNA CTD PMID:32812032 ketamine increases expression EXP 6480464 Ketamine results in increased expression of C1QC mRNA CTD PMID:20080153 ketamine multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [Ketamine results in decreased expression of C1QC mRNA] CTD PMID:31823199 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of C1QC mRNA CTD PMID:31823199 lansoprazole decreases expression EXP 6480464 Lansoprazole results in decreased expression of C1QC mRNA CTD PMID:25626140 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of C1QC mRNA CTD PMID:35283115 lipopolysaccharide increases expression ISO RGD:1315665 6480464 Lipopolysaccharides results in increased expression of C1QC mRNA CTD PMID:27339419 medroxyprogesterone acetate increases expression ISO RGD:1315664 6480464 Medroxyprogesterone Acetate results in increased expression of C1QC mRNA CTD PMID:20843944 methidathion increases expression ISO RGD:1315665 6480464 methidathion results in increased expression of C1QC mRNA CTD PMID:34813904 N-nitrosodiethylamine multiple interactions ISO RGD:1315665 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of C1QC mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression ISO RGD:1315665 6480464 Diethylnitrosamine results in increased expression of C1QC mRNA CTD PMID:17942915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of C1QC mRNA CTD PMID:19638242 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of C1QC mRNA CTD PMID:25380136 nickel atom increases expression ISO RGD:1315664 6480464 Nickel results in increased expression of C1QC mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate decreases expression ISO RGD:1315664 6480464 nickel sulfate results in decreased expression of C1QC mRNA CTD PMID:16780908 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of C1QC mRNA CTD PMID:24136188 omeprazole decreases expression EXP 6480464 Omeprazole results in decreased expression of C1QC mRNA CTD PMID:25626140 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of C1QC mRNA CTD PMID:18754875 pantoprazole decreases expression EXP 6480464 pantoprazole results in decreased expression of C1QC mRNA CTD PMID:25626140 paracetamol affects expression ISO RGD:1315665 6480464 Acetaminophen affects the expression of C1QC mRNA CTD PMID:17562736 phenobarbital multiple interactions ISO RGD:1315665 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of C1QC mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:1315665 6480464 Phenobarbital results in decreased expression of C1QC mRNA CTD PMID:19482888 pirinixic acid decreases expression ISO RGD:1315665 6480464 pirinixic acid results in decreased expression of C1QC mRNA CTD PMID:17426115 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of C1QC mRNA CTD PMID:27225895 pravastatin decreases expression ISO RGD:1315665 6480464 Pravastatin results in decreased expression of C1QC mRNA CTD PMID:27225895 probucol multiple interactions ISO RGD:1315665 6480464 Probucol promotes the reaction [APOE gene mutant form results in increased expression of C1QC mRNA] CTD PMID:19394937 rabeprazole decreases expression EXP 6480464 Rabeprazole results in decreased expression of C1QC mRNA CTD PMID:25626140 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of C1QC mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of C1QC mRNA CTD PMID:25905778 silicon dioxide decreases expression ISO RGD:1315665 6480464 Silicon Dioxide results in decreased expression of C1QC mRNA CTD PMID:23221170 silicon dioxide increases expression ISO RGD:1315665 6480464 Silicon Dioxide results in increased expression of C1QC mRNA CTD PMID:29341224 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of C1QC mRNA CTD PMID:21865292 Soman increases expression EXP 6480464 Soman results in increased expression of C1QC mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of C1QC mRNA CTD PMID:25905778 tacrolimus hydrate increases expression ISO RGD:1315665 6480464 Tacrolimus results in increased expression of C1QC mRNA CTD PMID:29362864 testosterone increases expression ISO RGD:1315665 6480464 Testosterone deficiency results in increased expression of C1QC mRNA CTD PMID:33848595 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QC mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:1315665 6480464 Carbon Tetrachloride results in increased expression of C1QC mRNA CTD PMID:27339419 , PMID:31919559 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA CTD PMID:33854195 titanium dioxide increases expression ISO RGD:1315665 6480464 titanium dioxide results in increased expression of C1QC mRNA CTD PMID:23557971 trimellitic anhydride increases expression ISO RGD:1315665 6480464 trimellitic anhydride results in increased expression of C1QC mRNA CTD PMID:16141432 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of C1QC mRNA CTD PMID:30589522 troglitazone increases expression ISO RGD:1315665 6480464 troglitazone results in increased expression of C1QC mRNA CTD PMID:28973697 valproic acid increases methylation ISO RGD:1315664 6480464 Valproic Acid results in increased methylation of C1QC gene CTD PMID:29154799 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of C1QC mRNA CTD PMID:23034163 zinc atom affects binding ISO RGD:1315664 6480464 C1QC protein binds to Zinc CTD PMID:23896426 zinc(0) affects binding ISO RGD:1315664 6480464 C1QC protein binds to Zinc CTD PMID:23896426
